Cortez A, Romero A, Mora O, Machuca R, Russo N, Guevara J, et al. Plan de farmacovigilancia activa para el producto REMODULIN® (TREPROSTINIL). AVFT [Internet]. 2015 Aug. 18 [cited 2025 Sep. 5];33(1). Available from: http://caelum.ucv.ve/ojs/index.php/rev_aavft/article/view/9184